Ranolazin Krka d.d. 375 mg tablete s produljenim oslobađanjem
Name | Ranolazin Krka d.d. 375 mg tablete s produljenim oslobađanjem |
---|---|
Marketing Authorisation Number | HR-H-117553040 |
Active Substance | ranolazin |
Composition | svaka tableta s produljenim oslobađanjem sadrži 375 mg ranolazina |
Pharmaceutical Form | Tableta s produljenim oslobađanjem |
Manufacturer | TAD Pharma Gmbh, Cuxhaven, Njemačka
Krka d.d., Novo mesto, Novo Mesto, Slovenija |
Marketing Authorisation Holder | Krka d.d., Novo mesto, Šmarješka cesta 6, Novo Mesto, Slovenija |
Marketing Authorisation Date | 03.02.2023 |
MA Period of Validity | 03.02.2028 |
Classification Number | UP/I-530-09/21-01/352 |
Registration Number | 381-12-01/171-23-10 |
Prescription | na recept |
Type of prescription | ponovljivi recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | C01EB18 |
SmPC | download |
PL | download |
Public Assessment Report | download |
Summary of risk management plan | download |